alexa
Reach Us +1-947-333-4405
Safety of Blood Transfusion: An Egyptian Study | OMICS International | Abstract
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Safety of Blood Transfusion: An Egyptian Study

Dalia Omran1*, Eiman A Hussein2 and Mohamad Nagib3
1 Department of Tropical Medicine, Cairo University, Egypt
2 Departments of Clinical Pathology and Hepatology, Cairo University, Egypt
3 Department of Internal Medicine, Cairo University, Cairo, Egypt
Corresponding Author : Dalia Omran
Faculty of Medicine
Department of Tropical Medicine
Cairo University, Nasr City, Egypt
Tel: +(202)01000087802
Fax: +(202)23649281
E-mail: [email protected]
Received December 04, 2013; Accepted December 13, 2013; Published December 17, 2013
Citation: Omran D, Hussein EA, Nagib M (2013) Safety of Blood Transfusion: An Egyptian Study. J Infect Dis Ther 1:124. doi: 10.4172/2332-0877.1000124
Copyright: © 2013 Omran D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Abstract

Introduction: Blood safety presents a serious challenge in Egypt, having the highest prevalence of hepatitis C virus (HCV).

Objectives: To evaluate the effectiveness of blood donor recruitment strategies, the seroprevalence of positive infectious markers among volunteer donors (VD) and family replacement donors (RD) at a University Hospital Blood Bank was studied.

Methodology: Donors’ records covering the period between 2006 and 2012 were reviewed. All donations had been tested using the following screening tests ; Ortho for HCV antibody (enzyme-linked immunosorbent assay test system Version 3.0, Ortho Clinical Diagnostics, Inc., Raritan, NJ) and Siemens (Siemens Enzygnost assay, Healthcare Diagnostic Products, Marburg, Germany) for HBsAg (Enzygnost HBsAg 6.0), human immune deficiency virus (HIV)-1 and HIV-2 antibodyies (Enzygnost HIV integral II), and syphilis antibodies. Reactive samples were not confirmed with additional tests.

Results: Of 308,762 donors, 63.4% were VD. The overall prevalence of HCV antibodies, HBsAg, human immunodeficiency virus (HIV) and syphilis antibodies were 4.3%, 1.22%, 0.07%, and 0.13%, respectively. After stratification for age and gender, all tested markers (except HIV) were significantly higher among RD.A significant decline in HCV seropositivity was observed in RD and VD from 8.9% and 4.2% in 2007/2008 to 3.8% and 1.5% in 2011/2012, respectively. A significant decrease in HBsAg was demonstrated in VD from 1.2% in 2007/2008 to 0.53% in 2011/2012. During the period 2007- 2011, an increasing trend for HIV and syphilis was noted.

Conclusion: The decreasing trend in HCV antibodies and HBsAg could be related to the strict donor selection criteria.

Keywords

Recommended Conferences
Share This Page
Top